Sopharma
is one of the leading pharmaceutical company in Bulgaria, popular with
manufacturing of high-quality medicines. In its striving to be among the
most successful firms, Sopharma combines traditions of the Bulgarian
pharmaceutical knoweldge with modern business ethic and corporate responsibility to
society's needs .
In the spring of 1933, in the suburbs of Sofia, the beginning of
Bulgarian pharmaceutical manufacture was initiated with the building of
the first manufacturing laboratory for pharmaceuticals. This was also
the beginning of Sopharma - one of the most successful Bulgarian
enterprises of all times. Irrespective of the form of property - private
cooperative, socialist state-owned, private joint-stock company, for 70
years now Sopharma continues to be an embodiment of the human striving
for health and humanity. This name symbolizes the work of many people
who for decades on end, carefully and responsibly, have been creating
remedies for the pains of other people. The trust of millions Bulgarians
is a priceless reward for their dedicated work. This explains the fact
that today as well Sopharma continues to be one of the largest
manufacturers of pharmaceuticals - a warrantor of quality and
reliability.
Established
as a small manufacturing laboratory with the Bulgarian Pharmaceutical
Cooperative Society in 1942, the company grew into Galenus Factory, the
first modern pharmaceutical enterprise on the Balkan Peninsula.
After its nationalization in 1953, Galenus Factory was renamed to
Chemical-Pharmaceutical Plant.
After the successful privatization in September 2000, Sopharma has
become a private pharmaceutical company with priorities aimed at the
establishment of the world standards for quality and efficiency.
The accomplishment of the investment program, adopted by Sopharma,
includes renovation of manufacture and technological facilities,
modernization of assets for research and development, restructuring of
research and development sector.
The ambitious investments are an expression of our clear conception of
the future which will help us to be among the best companies in the
pharmaceutical business and to create medicines as an actual
contribution to our care for human health.
The highly sophisticated process of the creation and manufacture of
pharmaceuticals has been licensed in compliance with the Good
Manufacturing Practices. The main production facilities have been
modernized and new production departments and plants have been opened.
The manufacture of high-quality pharmaceuticals complying with European
standards and Bulgarian legal regulations is a priority task in the
company policy of Sopharma.
A total of 110 medicines of almost all pharmaceutical groups, build the
product portfolio of our Company. Well-known in the country and abroad,
the pharmaceuticals with Sopharma's trademark are an approved guarantee
of quality and efficiency nowadays. |